Lawyers from the New York firm Kleinberg Kaplan Wolff & Cohen have taken the lead in opposing an agreement between Purdue Pharma and the attorneys general of 15 states that would clear the way for a $4.5 billion settlement and resolve thousands of opioid cases across the United States.

Kleinberg Kaplan partners Matthew Gold and Robert Tuchman represented Washington state and Oregon in a bankruptcy court filing Monday, which objected to Purdue’s reorganization plan for offering the company’s owners, the Sackler family, “blanket” lifetime immunity from civil suit in exchange for the multi-billion-dollar payment and the release of tens of millions of documents.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]